AK2 and lung adenocarcinoma: Similarly, the knockdown or knockout of AK2 inhibits the migration and invasive potential of human lung adenocarcinoma cells, while its overexpression promotes cancer metastasis, providing a rationale for targeting AK2 as a therapeutic approach for lung cancer [56].